Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
38.97
-0.10 (-0.26%)
At close: Mar 9, 2026, 4:00 PM EDT
39.35
+0.38 (0.98%)
After-hours: Mar 9, 2026, 6:33 PM EDT
Vera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,786 | 3,595 | 2,678 | 683 | 535 | 569 | |
| Market Cap Growth | 48.61% | 34.24% | 291.87% | 27.69% | -5.87% | - | |
| Enterprise Value | 2,113 | 3,175 | 2,380 | 553 | 433 | 482 | |
| Last Close Price | 39.07 | 50.64 | 42.29 | 15.38 | 19.35 | 26.72 | |
| PB Ratio | 4.61 | 5.95 | 4.64 | 6.72 | 6.96 | 8.17 | |
| P/TBV Ratio | 4.55 | 5.95 | 4.64 | 6.72 | 6.96 | 8.17 | |
| Debt / Equity Ratio | 0.13 | 0.13 | 0.10 | 0.53 | 0.41 | 0.07 | |
| Net Debt / Equity Ratio | -1.05 | -1.05 | -1.02 | -1.05 | -1.08 | -1.07 | |
| Net Debt / EBITDA Ratio | 2.02 | 2.02 | 3.51 | 1.05 | 0.92 | 2.18 | |
| Net Debt / FCF Ratio | 2.64 | 2.64 | 4.32 | 1.16 | 1.23 | 3.15 | |
| Quick Ratio | 13.43 | 13.43 | 25.41 | 7.23 | 4.48 | 10.36 | |
| Current Ratio | 13.64 | 13.64 | 25.67 | 7.71 | 4.91 | 10.73 | |
| Return on Equity (ROE) | -50.71% | -50.71% | -44.83% | -107.50% | -121.58% | -54.43% | |
| Return on Assets (ROA) | -28.36% | -28.36% | -25.14% | -41.54% | -52.81% | -31.09% | |
| Return on Capital Employed (ROCE) | -46.30% | -46.30% | -26.50% | -66.60% | -85.90% | -45.20% | |
| Earnings Yield | -10.89% | -8.33% | -5.68% | -14.05% | -16.64% | -5.74% | |
| FCF Yield | -8.79% | -6.73% | -5.07% | -13.50% | -12.64% | -4.17% | |
| Buyback Yield / Dilution | -16.10% | -16.10% | -29.55% | -60.73% | -97.76% | -4099.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.